Predict the Response to Acute Treatment of Migraine With Rimegepant 75 mg
NCT05888766
·
clinicaltrials.gov ↗
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Migraine Disorders
Interventions
DRUG:
Rimegepant 75 milligrams
Sponsor
University of Roma La Sapienza